Rein Therapeutics, Inc. ($RNTX)
Filing Information
| Accession Number | 0001193125-26-220718 |
|---|---|
| Form Type | 4 |
| Filing Date | May 13, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
175,000
Total Value
$25,000.00
P&L
+677.0% (+$169,250.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common stock , $0.001 par value | โ | Apr 30, 2026 | Purchase | 25,000 | $1.00 | $25,000.00 | 27,046 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | May 8, 2026 | Grant/Award | 150,000 | $0.00 | $0.00 | 150,000 | Direct | โ | View Details |